February 18, 2021
As Earth’s biodiversity declines, the perilous consequences are proving to only rise.
The destabilisation of national economies, threats to food systems, escalation of climate change, and likelihood of global pandemics such as COVID-19 are all increasingly linked to the loss of the planet’s variety of life.
This year, however, the United Nations (UN) Convention for Biological Diversity (CBD) is set to instate a new global plan for biodiversity conservation that will run through 2030, seeing nations and leaders commit to higher standards of protection and restoration of natural habitats and ecosystems.
Concurrently, 2021 also sees the launch of the UN Decade on Ecosystem Restoration, a 10-year effort to “prevent, halt and reverse the degradation of ecosystems worldwide”.
Nasdaq s CEO on biopharma, diversity, and GameStop
bio.org - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from bio.org Daily Mail and Mail on Sunday newspapers.
Salarius Pharmaceuticals to Present at BIO CEO & Investor Digital Conference
apnews.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from apnews.com Daily Mail and Mail on Sunday newspapers.
(3)
NEW YORK and LONDON, Feb. 16, 2021 (GLOBE NEWSWIRE) Tiziana Life Sciences plc (NASDAQ: TLSA / LSE: TILS) ( Tiziana or the Company ), a biotechnology company focused on innovative therapeutics for oncology, inflammation, and infectious diseases, today announced that it is presenting at the BIO CEO & Investor Digital Conference, 16-18
th February 2021.
Dr. Kunwar Shailubhai, CEO and CSO of Tiziana Life Sciences, commented, I look forward to sharing our exciting story with conference attendees. With the release of our topline data from our COVID-19 trial, multiple Phase 2 trial launches expected in 2021, and the potential application of Foralumab in a wide range of autoimmune and inflammatory diseases in the longer-term, we are well positioned to achieve a series of important milestones in the months and quarters ahead.